Netflix Co-CEO Defends Warner Bros. Asset Acquisition at Senate Antitrust Hearing
Summary
Netflix Co-CEO Ted Sarandos presented testimony to the Senate Judiciary Committee, defending the proposed acquisition of Warner Bros.' studios and HBO from Warner Bros. Discovery against antitrust concerns.
Key Events
-
Netflix Co-CEO Testifies Before Senate
Ted Sarandos, Co-CEO of Netflix, presented written testimony to the Senate Judiciary Committee Subcommittee on Antitrust, Competition Policy, and Consumer Rights.
-
Defends Proposed Warner Bros. Asset Acquisition
Sarandos argued that the acquisition of Warner Bros.' studios and HBO from Warner Bros. Discovery is pro-consumer, pro-jobs, and pro-innovation, addressing potential antitrust concerns.
-
Highlights Complementary Assets and Market Competition
The testimony emphasized Netflix's global reach and streaming innovation combined with Warner Bros.' iconic IP and production capabilities, asserting that the deal enhances competition in a fragmented entertainment market.
-
Follows Amended All-Cash Offer
This testimony comes shortly after Netflix amended its merger agreement to an all-cash transaction of $27.75 per share for the Warner Bros. assets, as disclosed on February 2, 2026.
Analysis
This DFAN14A contains the written testimony of Netflix Co-CEO Ted Sarandos before a Senate Judiciary Committee subcommittee, where he argued that the proposed acquisition of Warner Bros.' studios and HBO from Warner Bros. Discovery is pro-consumer, pro-jobs, and pro-innovation. Sarandos emphasized the complementary nature of the assets and the highly competitive entertainment landscape, aiming to alleviate antitrust concerns. This public defense is a critical step in securing regulatory approval for the significant transaction, especially following the recent amendment to an all-cash offer from Netflix and amidst a competing bid for Warner Bros. Discovery.
At the time of this filing, WBD was trading at $27.23 on NASDAQ in the Technology sector, with a market capitalization of approximately $67.4B. The 52-week trading range was $7.52 to $30.00. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.